4th Quarter - Report

ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Firm
Client
Income
—
Expenses
$564,518
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Free Trade Agrements - Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
CHARLES L KINNEY —
JASON R MONEY —

Contacted: Congressional Budget Office (CBO); Federal Trade Commission (FTC); White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Food & Drug Administration (FDA); SENATE; U.S. Trade Representative (USTR); Office of Management & Budget (OMB)

Pharmacy PHA

Generic Biologics, Health Care Reform, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs H.R.1427 and S.726 - Promoting Innovation and Access to Life-Saving Medicines Act, all provisions H.R.1548 - Pathway for Biosimilars Act, all provisions H.R.573, all provisions S.501 - Fair Prescription Drug Competition Act, all provisions S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies H.R.3962 - Affordable Health Care for America Act, Title I Subtitle B Part 3 Section 1149A - Payment for Biosimilar Biological Products; Title V Subtitle C Part 2 - Biosimilars

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
CHARLES L KINNEY —
JASON R MONEY —

Contacted: HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); SENATE; Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); White House Office; U.S. Trade Representative (USTR); Food & Drug Administration (FDA)

Bills named: S. 1232 (111th), H.R. 1298 (111th), H.R. 759 (111th), H.R. 3962 (111th), H.R. 1548 (111th), S. 726 (111th), S. 501 (111th), H.R. 1427 (111th), H.R. 3590 (111th), H.R. 573 (111th), S. 882 (111th), S. 525 (111th)

Copyright/Patent/Trademark CPT

Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent term extensions, Generic drugs S.515, S.610 and H.R.1260 - the Patent Reform Act of 2009, all provisions S.369 - Preserve Access to Affordable Generics Act, all provisions H.R.1706 - Protecting Consumers Access to Generic Drugs Act of 2009, all provisions H.R.3590 - Patient Protection and Affordable Care Act, Title VII Subtitle A - Biologics Price Competition and Innovation H.R.3962 - Affordable Health Care for America Act, Title V Subtitle C Part 2 - Biosimilars; Subtitle C Part 1 Section 2573 - Protecting Consumer Access to Generic Drugs

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
CHARLES L KINNEY —
JASON R MONEY —

Contacted: Commerce, Dept of (DOC); White House Office; Federal Trade Commission (FTC); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3590 (111th), H.R. 1260 (111th), S. 515 (111th), S. 610 (111th), H.R. 3962 (111th), H.R. 1706 (111th), S. 369 (111th)

Medicare/Medicaid MMM

Medicaid Reimbursement, Medicaid Rebates, The Deficit Reduction Act of 2006, prescription drug reimbursement, Average Manufacture Price (AMP)/AMP Publication, Expanding rebates to Part D program, generic drugs H.R.3962 - Affordable Health Care for America Act - Title I, Subtitle E - Improvements to Medicare Part D; Title V Subtitle A - Drug Discount for Rural and Other Hospitals; 340B Program Integrity; Title VII Subtitle E - Financing; H.R.3590 - Patient Protection and Affordable Care Act; Title II Subtitle F - Medicaid Prescription Drug Coverage; Title VII Subtitle B - More Affordable Medicines for Children and Underserved Communities

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
CHARLES L KINNEY —
JASON R MONEY —

Contacted: Food & Drug Administration (FDA); Commerce, Dept of (DOC); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Congressional Budget Office (CBO); White House Office; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3962 (111th), H.R. 3590 (111th)

Budget/Appropriations BUD

Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY2010 Presidential Budget Request, FY2010 Congressional Budget and Appropriations H.R.2997 and S.1406 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010 - Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
CHARLES L KINNEY —
JASON R MONEY —

Contacted: Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); White House Office; U.S. Trade Representative (USTR); Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Federal Trade Commission (FTC); SENATE

Bills named: H.R. 2997 (111th), S. 1406 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.